. . . . . . . "[JAK2 (V617F) is a risk factor for thrombosis in essential thrombocythemia/link may exist between leukocytosis, JAK2 (V617F), & the hemostatic system activation in patients with Bcl-negative myeloproliferative disorders/.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:03+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .